Eurobio Scientific Société anonyme
Eurobio Scientific Société anonyme operates in various business sectors.
Eurobio Scientific Société anonyme (E8TN) - Net Assets
Latest net assets as of December 2023: €175.17 Million EUR
Based on the latest financial reports, Eurobio Scientific Société anonyme (E8TN) has net assets worth €175.17 Million EUR as of December 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€316.33 Million) and total liabilities (€141.16 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €175.17 Million |
| % of Total Assets | 55.38% |
| Annual Growth Rate | 42.69% |
| 5-Year Change | 379.09% |
| 10-Year Change | N/A |
| Growth Volatility | 71.77 |
Eurobio Scientific Société anonyme - Net Assets Trend (2018–2023)
This chart illustrates how Eurobio Scientific Société anonyme's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Eurobio Scientific Société anonyme (2018–2023)
The table below shows the annual net assets of Eurobio Scientific Société anonyme from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €175.17 Million | +1.27% |
| 2022-12-31 | €172.98 Million | +7.53% |
| 2021-12-31 | €160.87 Million | +49.16% |
| 2020-12-31 | €107.85 Million | +194.95% |
| 2019-12-31 | €36.56 Million | +23.44% |
| 2018-12-31 | €29.62 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eurobio Scientific Société anonyme's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €175.17 Million | 100.00% |
| Total Equity | €175.17 Million | 100.00% |
Eurobio Scientific Société anonyme Competitors by Market Cap
The table below lists competitors of Eurobio Scientific Société anonyme ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Groupe Carnivor SA
PA:MLGRC
|
$232.48K |
|
EGLPV
OTCGREY:EGLPV
|
$232.58K |
|
SPMCV
OTCGREY:SPMCV
|
$232.80K |
|
BCP
BC:BCP
|
$233.06K |
|
Tesoro Minerals Corp
PINK:NNGVF
|
$232.34K |
|
MidCap Financial Investment Corporation 8.00% Notes due 2028
NASDAQ:MFICL
|
$232.33K |
|
Morgan Group Holding Co
PINK:MGHL
|
$232.13K |
|
SDX ENERGY PLCLS 001
F:3KX
|
$232.12K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eurobio Scientific Société anonyme's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 172,984,000 to 175,173,000, a change of 2,189,000 (1.3%).
- Net income of 4,835,000 contributed positively to equity growth.
- Share repurchases of 2,792,000 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €4.83 Million | +2.76% |
| Share Repurchases | €2.79 Million | -1.59% |
| Other Changes | €146.00K | +0.08% |
| Total Change | €- | 1.27% |
Book Value vs Market Value Analysis
This analysis compares Eurobio Scientific Société anonyme's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.39x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 8.13x to 1.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €2.99 | €24.30 | x |
| 2019-12-31 | €3.25 | €24.30 | x |
| 2020-12-31 | €9.51 | €24.30 | x |
| 2021-12-31 | €14.18 | €24.30 | x |
| 2022-12-31 | €16.92 | €24.30 | x |
| 2023-12-31 | €17.44 | €24.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eurobio Scientific Société anonyme utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.76%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.70%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.81x
- Recent ROE (2.76%) is below the historical average (20.37%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -9.35% | -5.42% | 0.73x | 2.36x | €-5.73 Million |
| 2019 | 8.62% | 5.30% | 0.73x | 2.22x | €-503.40K |
| 2020 | 68.14% | 38.84% | 1.10x | 1.60x | €62.70 Million |
| 2021 | 37.64% | 32.67% | 0.88x | 1.30x | €44.46 Million |
| 2022 | 14.42% | 16.31% | 0.46x | 1.91x | €7.64 Million |
| 2023 | 2.76% | 3.70% | 0.41x | 1.81x | €-12.68 Million |
Industry Comparison
This section compares Eurobio Scientific Société anonyme's net assets metrics with peer companies in the same industry.
No peer company data available for comparison.